A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects with Nonalcoholic Steatohepatitis and Fibrosis
Study title
A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects with Nonalcoholic Steatohepatitis and Fibrosis
Disease or condition
NASH-Nonalcoholic Steatohepatitis
Study type
Interventional (Clinical Trial)
Intervention/treatment
Saroglitazar Magnesium or Placebo
Phase
2b
Study site
Carolinas Medical Center, Center for Liver Disease and Transplant (Atrium Health)
Study location
Charlotte, NC
Principal investigator name and email
Andrew deLemos, andrew.delemos@atriumhealth.org
Study coordinator name and email
Marina Sycheva, marina.sycheva@atriumhealth.org
Phone Contact
704-446-4835
Clinicaltrials.gov link
https://clinicaltrials.gov/ct2/show/NCT05011305